Abivax (ABVX) Operating Interest Expenses (2024 - 2026)
Abivax's (ABVX) quarterly Operating Interest Expenses came in at $5.6 million in Q1 2026, little changed year-on-year from $5.6 million in Q1 2025, and down 81.69% quarter-over-quarter from $30.5 million in Q3 2025.
Abivax (ABVX) Operating Interest Expenses (2024 - 2026) Analysis & Trends
Abivax's Operating Interest Expenses history runs 3 years deep, the most recent figure standing at $5.6 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Abivax | 9.98 Bn | 9.98 Bn | - | 5.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.58 Mn |
| Mar 31, 2026 | 5.58 Mn |
| Sep 30, 2025 | 30.50 Mn |
| Sep 30, 2025 | 30.50 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Jun 30, 2025 | 5.72 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Mar 31, 2025 | 5.59 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Sep 30, 2024 | 7.35 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | 3.31 Mn |
| Mar 31, 2024 | 3.31 Mn |